MENU

China Becomes a Renewed Target in the 2020 Election

Katie Deal , Washington Analyst,
U.S. Equity Division

  • Read Time: 8 mins

Tensions mount over key issues in wake of the pandemic.

Following the coronavirus outbreak, renewed tensions between the U.S. and China have complicated the delicate détente that both countries reached through the tenuous phase I trade agreement—which halted the pattern of escalating tariffs and offered some incremental reforms to Chinese  market practices.

With the economic fallout caused by COVID‑19, the disease caused by the coronavirus, the Trump administration lost its ability to campaign on an expanding economy and record unemployment. Instead, the White House and the Republican Party have found an effective political target in China.

Though the Trump administration has viewed China as a “strategic adversary” throughout its tenure, its party now sees “tough on China” rhetoric as a key strategy to keep voters committed to the president. Consequently, investors are now reconsidering the security of the phase I trade deal—and wondering what other regulations could come next.

Facing a Multi-front Battle in an Increasingly Protectionist World

The Trump administration recently took actions across three key policy areas related to China: critical technology, national security, and economic protectionism.

Critical technology, a long‑standing concern in the U.S.‑China relationship, has garnered renewed attention. Given competition in cutting‑edge technologies like 5G, the U.S. has pursued policies that will both protect and incentivize next‑generation industrial dominance while addressing crucial national  security concerns.

…renewed tensions between the U.S. and China have complicated the delicate détente that both countries reached through the tenuous phase I trade agreement…

The U.S. Commerce Department recently adopted regulations aimed at securing the supply chains of technologies like semiconductors from Chinese government interference. These rules—combined with tighter restrictions on the Chinese telecommunications giant Huawei—send a clear signal: The U.S. will continue to impose policies that attempt to give it a critical technology advantage over China.
Meanwhile, Congress has introduced several bills in response to China’s initial handling of the coronavirus outbreak, as well as its recent actions in Hong Kong, including a reparations and sanctions act against officials connected to the coronavirus response, legislation removing China’s sovereign immunity against lawsuits, and new legislation addressing the erosion of autonomy in Hong Kong and the protections held by Tibet. Though few may become law, these bills indicate a clear legislative trend likely to continue well beyond 2020.

“Reshoring” of Supply Chains Gains Traction

Additionally, the coronavirus has renewed conversations about the “reshoring” of supply chains, beginning with those critical to fighting COVID‑19. Congress and the White House are actively developing incentive packages to encourage certain manufacturers of personal protective equipment and other medical supplies to return production to the U.S., as well as to attract a broader swath of industrial production.
Sector‑wide reshoring will take decades of continuous government support and strategic planning by companies, regardless of industry. Nevertheless, we expect these conversations to continue into the next administration—regardless of which party wins the White House.

U.S. Moves Could Result in Delisting of Some Companies

The United States has also identified financial markets as a battleground against China—for reasons related to both national security and market openness. For years, the Public Company Accounting Oversight Board (PCAOB) has flagged “China‑Related Access Challenges” that have hindered the agency’s capacity to gain “complete and timely access” for inspections and investigations of Chinese public companies.

No matter which party controls the White House in 2021, we should not expect a significant shift in the increasingly negative trajectory of the U.S.-China relationship…

In an effort to bolster the U.S. capacity to audit these firms, the Senate passed the Holding Foreign Companies Accountable Act (HFCA), which would require the public companies to disclose if they are “owned or controlled by a foreign government” like the Chinese Communist Party and would give a company three years to comply with PCAOB audits—or risk delisting from  U.S. exchanges.
After months of efforts to reconsider U.S. federal pension investment in Chinese stocks, the Senate unanimously passed HFCA. The bill is awaiting consideration in the House of Representatives. Though the measure’s future is uncertain, key members of Congress are committed to heightening the regulatory risk profiles of Chinese firms.

More Friction on the Horizon

No matter which party controls the White House in 2021, we should not expect a significant shift in the increasingly negative trajectory of the U.S.‑China relationship, particularly with China also taking a harder line to protect its interests.
Though the flurry of anti‑China action within the U.S. government may have been catalyzed by the politics of the coronavirus, the critical issues that have resurfaced will not fade in the short term. In fact, they may define the conversation in the inevitable next round of negotiations—diplomatic or economic—between the U.S. and Chinese governments.

Sign up for US Equity insights from T. Rowe Price

Share this article:

Share on linkedin
Share on email

Important Information

For professional clients only. Not for further distribution.

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.

This material is issued and approved by T. Rowe Price International Ltd, 60 Queen Victoria Street, London, EC4N 4TZ which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.

© 2020 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks or registered trademarks of T. Rowe Price Group, Inc.

202006‑1214173

You might be interested in…

See our comprehensive range of US equity funds

Thank you for registering for US equities updates. The latest insights will be sent straight to your inbox, in the meantime access our latest thinking:

Important Legal Information

This site is intended for financial intermediaries in the United Kingdom. I have read the terms detailed below and confirm that I am a financial intermediary and that I wish to proceed. By accessing this website, you consent to T. Rowe Price collecting information by way of cookies.

Information contained in the T. Rowe Price website is not intended for investors in any jurisdiction in which distribution or purchase is not authorised, including the jurisdiction of the reader of this information, where applicable. For example, the information herein is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of United States persons.

Information obtained from this site is intended specifically for the individuals who have agreed to these Terms and Conditions and may not be redistributed without prior consent from the T. Rowe Price Legal department.

The information is designed for professional investors, including financial intermediaries or members of the media, and is published for informational purposes only. In particular, the information is directed at only informing persons falling within one or more of the following categories:

(a) A government;
(b) A bank or insurance company;
(c) A pension fund or charity;
(d) Persons whose ordinary activities involve them, as principal or as agent, in acquiring, holding, managing or disposing of investments for the purposes of a business carried on by them or whom it is reasonable to expect will, acquire, manage or dispose of investments for the purpose of such a business;
(e) Persons whose ordinary business involves the giving of advice, which may lead to another person acquiring or disposing of an investment or refraining from so doing;
(f) Representatives of the media for corporate and background information about T. Rowe Price.

Persons who do not fall into one of the above categories should not act upon the information contained herein.

Certain persons may have access to information regarding the T. Rowe Price Funds SICAV, an investment company incorporated as “Société d’Investissement à Capital Variable” (‘SICAV’) under the laws of Luxembourg and the T. Rowe Price Funds OEIC, an open-ended investment company (‘OEIC’) incorporated in England and Wales. The sub-funds referred to on the site are only offered by the current prospectus. The prospectus contains more complete information about the sub-funds, including investment objectives, charges and expenses. However, the prospectus and other information relating to the sub-funds will not be intentionally distributed to persons in any country where such distribution would be contrary to local law or regulation.

Past performance is not a guide to future performance. The value of securities and any income generated from them might decrease as well as increase. Changes in rates of exchange may also have an adverse effect on the value, price or income of securities. Investors should also be aware of the additional risks associated with investments in emerging markets, high yield securities and smaller companies.

This information herein does not constitute investment advice and the products described may not be available to or suitable for all investors. You should consider, if appropriate, obtaining independent professional advice before making an investment decision.

Unless otherwise noted, the content appearing in this Section of the T. Rowe Price website has been issued by T. Rowe Price International Ltd, 60 Queen Victoria Street, London EC4N 4TZ, which is authorised and regulated by the U.K. Financial Conduct Authority with the reference number 194667.